Core Viewpoint - 中航沈飞's stock price has experienced a decline recently, with a year-to-date increase of 21.90%, indicating potential volatility in the market [1][2]. Financial Performance - As of September 30, 中航沈飞 reported a revenue of 20.607 billion yuan, a year-on-year decrease of 18.54% [2]. - The net profit attributable to shareholders for the same period was 1.362 billion yuan, down 25.10% year-on-year [2]. Stock Market Activity - On October 31, 中航沈飞's stock price fell by 2.03%, trading at 61.34 yuan per share with a total transaction volume of 906 million yuan [1]. - The stock's turnover rate was 0.53%, and the total market capitalization reached 173.905 billion yuan [1]. - There was a net outflow of 100 million yuan in principal funds, with significant selling pressure observed [1]. Shareholder Information - The number of shareholders as of September 30 was 100,000, a decrease of 19.80% from the previous period [2]. - The average number of circulating shares per shareholder increased by 24.69% to 27,472 shares [2]. Dividend Distribution - 中航沈飞 has distributed a total of 4.356 billion yuan in dividends since its A-share listing, with 2.992 billion yuan distributed over the past three years [3]. Institutional Holdings - As of September 30, the top ten circulating shareholders included 富国中证军工龙头ETF, which increased its holdings by 3.5933 million shares [3]. - Other notable changes in institutional holdings included a decrease in shares held by 华夏上证50ETF and 华泰柏瑞沪深300ETF [3].

Investment Rating - The report maintains a "Recommended" rating for the company [4][6]. Core Insights - The company reported a revenue of 20.607 billion yuan for the first three quarters of 2025, a year-over-year decrease of 18.54%, with a net profit attributable to shareholders of 1.362 billion yuan, down 25.10% year-over-year. The performance aligns with expectations [1]. - In the third quarter of 2025, the company achieved a revenue of 5.978 billion yuan, reflecting a year-over-year increase of 62.77%, and a net profit of 225 million yuan, up 12.89% year-over-year. Profitability remained stable overall [1]. - The company successfully raised 4 billion yuan through a private placement to enhance its equipment development and improve maintenance capabilities through an investment in its subsidiary [3][4]. Financial Performance Summary - For the first three quarters of 2025, the company's gross margin decreased by 0.65 percentage points to 11.83%, while the net profit margin fell by 0.50 percentage points to 6.64%. The gross margin for Q3 2025 was 10.79%, down 1.42 percentage points year-over-year, and the net profit margin was 3.96%, down 1.27 percentage points year-over-year [1]. - The company experienced a significant increase in prepaid supplier payments, which rose by 104.17% to 4.230 billion yuan compared to the beginning of the year. Accounts receivable increased by 2.73% to 20.388 billion yuan, while inventory decreased by 5.09% to 12.909 billion yuan [2]. - The company forecasts net profits attributable to shareholders of 3.030 billion yuan, 3.817 billion yuan, and 4.624 billion yuan for 2025, 2026, and 2027, respectively, with corresponding PE ratios of 59x, 47x, and 38x [4][5].

Core Insights - The company reported a revenue of 20.607 billion yuan for the first three quarters of 2025, representing a year-on-year decline of 18.54% [1] - The net profit attributable to shareholders was 1.362 billion yuan, down 25.1% year-on-year [1] - The net profit after deducting non-recurring items was 1.301 billion yuan, reflecting a decrease of 27.17% year-on-year [1] - The basic earnings per share stood at 0.50 yuan [1]

Group 1: Guizhou Moutai - Guizhou Moutai reported a net profit of 646.27 billion yuan for the first three quarters of 2025, an increase of 6.25% year-on-year [1][2] - The company's revenue for the first three quarters reached 1,284.54 billion yuan, reflecting a growth of 6.36% compared to the previous year [1][2] Group 2: Midea Group - Midea Group achieved a net profit of 378.83 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 19.51% [3][4] - The company's revenue for the same period was 3,630.57 billion yuan, up 13.82% year-on-year [3][4] Group 3: Mindray Medical - Mindray Medical reported a net profit of 75.7 billion yuan for the first three quarters of 2025, a decline of 28.83% year-on-year [5][6] - The company's revenue for the first three quarters was 258.34 billion yuan, down 12.38% compared to the previous year [5][6] Group 4: SanHuan Group - SanHuan Group's net profit for the first three quarters of 2025 was 19.59 billion yuan, reflecting a growth of 22.16% year-on-year [7][8] - The company's revenue for the same period reached 65.08 billion yuan, an increase of 20.96% year-on-year [7][8] Group 5: Longyuan Power - Longyuan Power reported a net profit of 43.93 billion yuan for the first three quarters of 2025, a decrease of 21.02% year-on-year [9][10] - The company's revenue for the same period was 222.21 billion yuan, down 17.29% compared to the previous year [9][10] Group 6: China Nuclear Power - China Nuclear Power's net profit for the first three quarters of 2025 was 80.02 billion yuan, a decline of 10.42% year-on-year [12][13] - The company's revenue for the same period reached 616.35 billion yuan, an increase of 8.16% year-on-year [12][13] Group 7: Fenjie Media - Fenjie Media reported a net profit of 42.40 billion yuan for the first three quarters of 2025, an increase of 6.87% year-on-year [14][15] - The company's revenue for the same period was 96.07 billion yuan, reflecting a growth of 3.73% year-on-year [14][15] Group 8: Tianfu Communication - Tianfu Communication achieved a net profit of 14.65 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 50.07% [17][18] - The company's revenue for the same period was 39.18 billion yuan, up 63.63% year-on-year [17][18] Group 9: Lingyi Technology - Lingyi Technology reported a net profit of 19.41 billion yuan for the first three quarters of 2025, reflecting a growth of 37.66% year-on-year [19][20] - The company's revenue for the same period reached 375.90 billion yuan, an increase of 19.25% year-on-year [19][20] Group 10: Rongsheng Petrochemical - Rongsheng Petrochemical's net profit for the first three quarters of 2025 was 8.88 billion yuan, a growth of 1.34% year-on-year [21] - The company's revenue for the same period was 2,278.15 billion yuan, down 7.09% compared to the previous year [21] Group 11: ShenNan Circuit - ShenNan Circuit reported a net profit of 23.26 billion yuan for the first three quarters of 2025, an increase of 56.30% year-on-year [22] - The company's revenue for the same period was 167.54 billion yuan, reflecting a growth of 28.39% year-on-year [22] Group 12: Jiangbolong - Jiangbolong achieved a net profit of 7.13 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 27.95% [23] - The company's revenue for the same period reached 167.34 billion yuan, up 26.12% year-on-year [23] Group 13: New Yisheng - New Yisheng reported a net profit of 63.27 billion yuan for the first three quarters of 2025, reflecting a growth of 284.37% year-on-year [24] - The company's revenue for the same period was 165.05 billion yuan, an increase of 221.70% year-on-year [24] Group 14: China Merchants Bank - China Merchants Bank achieved a net profit of 1,137.72 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 0.52% [25] - The company's revenue for the same period was 2,514.2 billion yuan, down 0.51% compared to the previous year [25] Group 15: Zhongwei Company - Zhongwei Company reported a net profit of 12.11 billion yuan for the first three quarters of 2025, a growth of approximately 32.66% year-on-year [26] - The company's revenue for the same period reached 80.63 billion yuan, an increase of approximately 46.40% year-on-year [26] Group 16: Microchip Biotech - Microchip Biotech's non-public offering was approved, aiming to raise up to 9.5 billion yuan for innovative drug research and development [27] Group 17: Longyuan Power's Fundraising - Longyuan Power plans to raise up to 50 billion yuan through a private placement to invest in renewable energy projects [28] Group 18: North University Pharmaceutical - North University Pharmaceutical's chairman was detained for investigation, but the company's operations remain normal [29] Group 19: Deyang Shares - Deyang Shares reported a net profit of 23.47 billion yuan for the first three quarters of 2025, a growth of 4.79% year-on-year [30] Group 20: Xiechuang Data - Xiechuang Data achieved a net profit of 6.98 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 25.30% [31] Group 21: Zhifei Biological - Zhifei Biological reported a net loss of 12.06 billion yuan for the first three quarters of 2025, primarily due to lower sales and increased provisions [32] Group 22: Softcom Power - Softcom Power achieved a net profit of 9.89 billion yuan for the first three quarters of 2025, reflecting a growth of 30.21% year-on-year [33] Group 23: Magmi Technology - Magmi Technology reported a net profit of 2.13 billion yuan for the first three quarters of 2025, a decline of 48.29% year-on-year [34] Group 24: Huali Group - Huali Group's net profit for the first three quarters of 2025 was 24.35 billion yuan, a decrease of 14.34% year-on-year [35]

Group 1 - The core point of the article is that AVIC Shenyang Aircraft Corporation (中航沈飞) announced the convening of its 19th board meeting on October 29, 2025, to discuss the reappointment of an accounting firm and other related documents [1] - For the fiscal year 2024, the revenue composition of AVIC Shenyang is as follows: 99.33% from the aviation manufacturing sector, 0.58% from other businesses, and 0.1% from miscellaneous sources [1] - As of the report date, the market capitalization of AVIC Shenyang is 181.8 billion yuan [1]

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The total operating revenue for the first three quarters reached 20.607 billion yuan, representing a year-on-year decrease of 18.54% [1] - The net profit attributable to shareholders was 1.362 billion yuan, down 25.1% year-on-year [1] - The basic earnings per share were reported at 0.5 yuan [1] Dividend Announcement - The company plans to distribute a cash dividend of 1.4 yuan (including tax) for every 10 shares to all shareholders [1]

证券代码：600760 证券简称：中航沈飞 公告编号：2025-053 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 中航沈飞股份有限公司（以下简称"公司"）第十届董事会第十九次会议（以 下简称"本次会议"）于 2025 年 10 月 20 日以电子邮件方式发出会议通知，并 于 2025 年 10 月 29 日在沈飞宾馆会议室以现场投票表决的方式召开。 本次会议应出席董事 12 名，实际出席董事 12 名，纪瑞东董事长因公务授权 委托李建董事出席会议并行使表决权，刘志敏董事因公务授权委托陈顺洪董事出 席会议并行使表决权，邢一新董事因公务授权委托王仁泽董事出席会议并行使表 决权。公司董事李建主持本次会议，公司部分高级管理人员列席了会议。本次会 议召开符合有关法律、行政法规、规范性文件和《公司章程》的规定。 二、董事会会议审议情况 （一）审议通过《关于中航沈飞 2025 年第三季度报告的议案》 《中航沈飞股份有限公司 2025 年第三季度报告》详见上海证券交易所网站 www.sse.com.cn。 表决情 ...

中信建投证券股份有限公司关于中航沈飞股份有限公司 使用部分募集资金向控股子公司增资以实施募投项目暨关 联交易的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"、"保荐人"）作为 中航沈飞股份有限公司（以下简称"中航沈飞"、"公司"）2023 年度向特定对象发 行 A 股股票项目的保荐人，根据《证券发行上市保荐业务管理办法》《上市公 司募集资金监管规则》《上海证券交易所股票上市规则》《上海证券交易所上市 公司自律监管指引第 1 号——规范运作》《上海证券交易所上市公司自律监管指 引第 11 号——持续督导》等法律法规、规范性文件的要求，对公司使用部分募 集资金向控股子公司增资以实施募投项目暨关联交易事项进行了审慎核查，具体 情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意中航沈飞股份有限公司向特定对象发 行股票注册的批复》（证监许可〔2025〕630 号）同意注册，中航沈飞向特定对 象发行人民币普通股（A 股）80,000,000 股，每股发行价格为人民币 50.00 元， 募集资金总额为人民币 4,000,000,000.00 元；扣除保荐费及承销费（不含增值税） 人民币 29 ...

中航证券有限公司（以下简称"中航证券"、"保荐人"）作为中航沈飞股份 有限公司（以下简称"中航沈飞"、"公司"）2023 年度向特定对象发行 A 股股票 项目的保荐人，根据《证券发行上市保荐业务管理办法》《上市公司募集资金监 管规则》《上海证券交易所股票上市规则》《上海证券交易所上市公司自律监管 指引第 1 号——规范运作》《上海证券交易所上市公司自律监管指引第 11 号— —持续督导》等法律法规、规范性文件的要求，对公司使用部分募集资金向控股 子公司增资以实施募投项目暨关联交易事项进行了审慎核查，具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意中航沈飞股份有限公司向特定对象发 行股票注册的批复》（证监许可〔2025〕630 号）同意注册，中航沈飞向特定对 象发行人民币普通股（A 股）80,000,000 股，每股发行价格为人民币 50.00 元， 募集资金总额为人民币 4,000,000,000.00 元；扣除保荐费及承销费（不含增值税） 人民币 29,245,283.02 元，募集资金实际到账金额为人民币 3,970,754,716.98 元； 另扣除印花税及发行登记费（不含增值税 ...

（此页无正文，系《中航沈飞股份有限公司董事会独立董事专门会议 2025 年第四次会议的审核意见》签署页） 中航沈飞股份有限公司 独立董事专门会议 2025 年第四次会议 中航沈飞股份有限公司董事会独立董事专门会议 2025 年第四次会议的审核意见 根据《上市公司独立董事管理办法》《上海证券交易所股票上市规则》等 法律、法规和规范性文件及《中航沈飞股份有限公司章程》的有关规定，作为 中航沈飞股份有限公司（以下简称"公司"）的独立董事，我们召开了公司董 事会独立董事专门会议 2025 年第四次会议，对拟提交公司第十届董事会第十 九次会议审议的《关于中航沈飞使用部分募集资金向控股子公司增资以实施募 投项目暨关联交易的议案》发表如下审核意见： 公司本次使用募集资金向控股子公司吉林航空维修有限责任公司增资是 基于公司募投项目建设的需要，有利于募投项目的推进实施，符合募集资金的 使用计划。该募集资金的使用方式、用途及决策程序符合有关法律、法规、规 范性文件及公司《募集资金管理制度》的相关规定。本次关联交易公平、合理， 符合公司和全体股东的利益，不存在改变募集资金用途、投向及其他损害公司 及股东特别是中小股东利益的情形。我 ...